Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: MarcG who wrote (88)	12/9/1997 2:44:00 PM
From: David Wideman	Read Replies (1) \| Respond to of 4028

Cliff's Notes from conversation with Steve Sloat last night: I had e-mailed Steve a couple of weeks ago in reference to an article I had read on cancer research in my local paper. He called last night, apologizing for the delay, but he's been swamped. My thoughts are still that it's mighty nice of a guy like this to spend time talking with an individual investor like myself. Plus the fact that he's an interesting fella to talk with, over and above the company/stock perspective. Anyway, I don't have a lot to add to the post of my previous conversation with Steve, but it's still there for those interested. Steve re-iterated much of this info, seems that if anything, plans are proceeding even better than thought just 2-3 weeks ago. Maybe some points of interest: CYGS is currently a non-reporting company. Steve's goal is to change this over the coming months, as he is planning to move CYGS to either the Philadelphia or Boston Exchange, followed by a move in due time (when financial strength allows) to AMEX or NASDAQ Small Cap. Financing secured for next 12 months, to cover payroll, R & D, etc. One patent in hand, a couple of patent apps in process. Best guess at price movement yesterday is that 7-8 brokers have been doing all DD possible on CYGS, some of them are evidently excited about the prospects and buying in. Thought to be a lot of short shares. Long-term holders (vs. traders) can combat this by requesting stock certificates. Estimate only = 600K shares held short. (Volume has been tremendous for a company with only 2.8M shares in float.) Last week's meeting with research scientists revealed that research is ahead of schedule. I'm not a clinical psychologist (though friends have told me that I might need to see one), but Steve seemed genuinely excited about this. Therefore, I am, too. Company will have name change in next few weeks. New name will be U.S. Biogenix, a subsidiary of CSI. Website will be updated in the next week or so. Wishes this had already been done, but again, they've all been swamped with more pressing matters. I don't know if this update will contain any new developments, Steve did say that Board and staff info will be included. Sounds like they've got a great team in all facets of the business. In addition to the big-ticket item in many minds - cancer research - it sure sounds like the shrimp farming is going to bring in significant $ in the future. So what does all of this rambling add up to? IMHO, the next few months should prove to be real interesting (and profitable, too!!! . . . I said IMHO, remember?). Happy holidays to all, David